Securities code: Guangdong Marubi Biotechnology Co.Ltd(603983) securities abbreviation: Guangdong Marubi Biotechnology Co.Ltd(603983) Announcement No.: 2022021
Guangdong Marubi Biotechnology Co.Ltd(603983)
Suggestive announcement on changes in shareholders’ equity
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
This equity change belongs to share reduction, does not touch the tender offer, and will not change the controlling shareholder and actual controller of the company.
After this equity change, the information disclosure obligor holds less than 5% of the shares of the listed company and is no longer a shareholder of more than 5% of the company.
Reasons for changes in equity
L Capital Asia, LLC is a professional private equity investment institution. L capital Guangzhou beauty Ltd. is the main body established by L Capital Asia, LLC to invest in Guangdong Marubi Biotechnology Co.Ltd(603983) and took shares in Guangdong Marubi Biotechnology Co.Ltd(603983) in May 2013. It has been nine years since then. During this period, l capital Guangzhou beauty Ltd. has established a friendly and mutually trusted cooperative relationship and has always been optimistic about the development and future of Guangdong Marubi Biotechnology Co.Ltd(603983) .
Since l capital has held Guangdong Marubi Biotechnology Co.Ltd(603983) shares for a long time, as an equity investment company, it has its own capital withdrawal needs.
Guangdong Marubi Biotechnology Co.Ltd(603983) (hereinafter referred to as “the company”) received the Guangdong Marubi Biotechnology Co.Ltd(603983) simplified equity change report from L capital Guangzhou beauty Ltd. (hereinafter referred to as “lcapital”), a shareholder holding more than 5% of the company’s shares, on May 22, 2022. Now, the relevant equity changes are announced as follows:
Before this equity change, l capital held 26999194 shares of the company, accounting for about 671923% of the total share capital of the company. After this equity change, l capital holds 20090880 shares of the company, accounting for about 499998% of the total share capital of the company. L capital is no longer a shareholder of Guangdong Marubi Biotechnology Co.Ltd(603983) holding more than 5%.
1、 Basic information of this equity change
Information name / Name: l capital Guangzhou beauty Ltd
Disclosure obligation
Human basic suite 401, 4th floor, Ebene Esplanade, 24
Information address: CyberCity, Ebene, Mauritius
Change method change date share type reduction number of shares reduction proportion of equity change (share) (%)
Details of movements from May 20, 2022 to
Block trading reduction of RMB ordinary shares 6908314171926 on May 20, 2022
Total — 6908314171926
2、 Before and after this equity change, the shares of the company’s equity owned by the information disclosure obligor
Proportion of shares held by shareholders after the change in the total share capital (%)
L capital unlimited conditions 2699919467192320090880499998 tradable shares
1. All the shares involved in this equity change enjoy voting rights, and there are no rights restrictions or restricted transfers such as voting rights entrustment or restriction.
2. This change does not violate the provisions of relevant laws, regulations and normative documents such as the securities law, the measures for the administration of the acquisition of listed companies and the relevant commitments of L capital.
3. There are differences in the mantissa between the sum of some totals and addends in this report. These differences are caused by rounding.
3、 Other information
1. This equity change is a reduction of holdings and does not involve the source of funds.
2. This equity change will not lead to changes in the controlling shareholders and actual controllers.
3. According to the relevant provisions of the measures for the administration of the acquisition of listed companies, the information disclosure obligor has prepared a simplified equity change report in accordance with the provisions. For details, see the Guangdong Marubi Biotechnology Co.Ltd(603983) simplified equity change report disclosed by the company on the same day.
It is hereby announced
Guangdong Marubi Biotechnology Co.Ltd(603983) board of directors may 23, 2022
